InvestorsHub Logo
Followers 84
Posts 10462
Boards Moderated 0
Alias Born 02/25/2004

Re: Lone Wolf post# 512

Thursday, 12/22/2016 11:49:38 AM

Thursday, December 22, 2016 11:49:38 AM

Post# of 625
I'm in TKAI on this announcement. Current TKAI shareholders will own 40% of the new company. Already approved merger by boards. This should run.

Under the terms of the agreement, the shareholders of Otic Pharma will receive a total of 32,172,209 shares of newly issued Tokai common stock, while outstanding Otic Pharma options and convertible securities will be assumed by Tokai. Upon the exchange, it is expected that existing Tokai stockholders will own approximately 40% of the combined company, with existing Otic Pharma shareholders owning approximately 60%. The transaction has been unanimously approved by the boards of directors of both companies and shareholders of Otic Pharma. Tokai's largest stockholder, Apple Tree Partners, who holds approximately 35% of Tokai's common stock has entered into an agreement in support of the proposed transaction. The transaction is expected to close during the first quarter of 2017, subject to customary closing conditions, including approval by shareholders of Tokai.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.